The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound vendor, at $23 a share.
The offer, which would merge the American firm into a wholly owned subsidiary of Siemens and create the world's largest ultrasound company, remains conditional on expiration of the waiting period under U.S. antitrust law.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.